Skip to main content
SpringerLink
Log in

LC-HRMS based metabolomics screening model to detect various β-agonists treatments in bovines

  • Original Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

A study was performed to determine if untargeted metabolomics of urine could be used to establish a predictive tool for identifying β-agonists misuse in cattle. Although prohibited for more than 20 years within the EU, growth promoting practices for livestock fattening purposes are still suspected. Methods based on gas- or liquid chromatography coupled to (tandem) mass spectrometry are today considered as the state-of-the-art to monitor, in a targeted approach, residues of known drugs. To overcome the detection of anabolic practices, new synthetic xenobiotic growth promoters have been designed and new ways of applications, such as the administration of low dose cocktails, have been developed. In this context, innovative screening strategies are urgently needed to enable efficient control of such practices. Omic technologies have recently shown their relevance in highlighting physiological response resulting from anabolic compounds administration. LC-HRMS based metabolomics is one of the approaches allowing profiling biological matrices to reveal biological effects of a drug. In the present work, a metabolomics study performed on urine samples collected in the frame of several independent experiments involving different animals, different β-agonists treatments and different parameters (doses, compounds mixture, treatment length), allowed highlighting biomarkers of interest and implementing a robust statistical model to predict for β-agonists treated bovines. Performances of the proposed model fit with EU requirements for screening methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Antignac, J. P., Courant, F., Pinel, G., Bichon, E., Monteau, F., Elliott, C., et al. (2011). Mass spectrometry-based metabolomics applied to the chemical safety of food. TrAC, Trends in Analytical Chemistry, 30(2), 292–301. doi:10.1016/j.trac.2010.11.003.

    Article  CAS  Google Scholar 

  • Boyard-Kieken, F., Dervilly-Pinel, G., Garcia, P., Paris, A. C., Popot, M. A., le Bizec, B., et al. (2011). Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control. [Comparative Study Research Support, Non-U.S. Gov’t]. Journal of Separation Science, 34(24), 3493–3501. doi:10.1002/jssc.201100223.

    Article  CAS  PubMed  Google Scholar 

  • Council Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002). Official Journal of the European Union.

  • Council Directive 88/146/EEC prohibiting the use livestock farming of certain substances having a hormonal action Official Journal of the European Union (1988). (16), 16-18.

  • Council Directive 96/23/EU on measures to monitor certain substances and residues thereof in live animals and animal products Official Journal of the European Union L125 (1996). 96/23/EC(10).

  • Courant, F., Pinel, G., Bichon, E., Monteau, F., Antignac, J. P., & Le Bizec, B. (2009). Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves. [Research Support, Non-U.S. Gov’t]. Analyst, 134(8), 1637–1646. doi:10.1039/b901813a.

    Article  CAS  PubMed  Google Scholar 

  • Cunningham, R., Mooney, M., Xia, X., Crooks, S., Matthews, D., O’Keefe, M., et al. (2009). Feasibility of a clinical chemical analysis approach to predict misuse of growth promoting hormones in cattle. Analytical Chemistry, 81, 977.

    Article  CAS  PubMed  Google Scholar 

  • Dervilly-Pinel, G., Weigel, S., Lommen, A., Chereau, S., Rambaud, L., Essers, M., et al. (2011). Assessment of two complementary liquid chromatography coupled to high resolution mass spectrometry metabolomics strategies for the screening of anabolic steroid treatment in calves. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta, 700(1–2), 144–154. doi:10.1016/j.aca.2011.02.008.

    Article  CAS  PubMed  Google Scholar 

  • Dervilly-Pinel, G., Courant, F., Chereau, S., Royer, A., Boyard-Kieken, F., Antignac, J., et al. (2012). Metabolomics in food analysis: Application to the control of forbidden substances. Drug Testing and Analysis, 4, 10.

    Article  Google Scholar 

  • Jacob, C. C., Dervilly-Pinel, G., Biancotto, G., & Le Bizec, B. (2013). Evaluation of specific gravity as normalization strategy for cattle urinary metabolome analysis. Metabolomics,. doi:10.1007/s11306-013-0604-z.

    Google Scholar 

  • Jacob, C., Dervilly-Pinel, G., Biancotto, G., Monteau, F., & Le Bizec, B. (2014). Global urine fingerprinting by LC-ESI(+)-HRMS for better characterization of metabolic pathway disruption upon anabolic practices in bovine. Metabolomics,. doi:10.1007/s11306-014-0685-3.

    Google Scholar 

  • Kaabia, Z., Dervilly-Pinel, G., Popot, M. A., Bailly-Chouriberry, L., Plou, P., Bonnaire, Y., et al. (2014). Monitoring the endogenous steroid profile disruption in urine and blood upon nandrolone administration: an efficient and innovative strategy to screen for nandrolone abuse in horses. Drug Testing and Analysis,. doi:10.1002/dta.1520.

    PubMed  Google Scholar 

  • Kieken, F., Pinel, G., Antignac, J. P., Monteau, F., Christelle Paris, A., Popot, M. A., et al. (2009). Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine. [Research Support, Non-U.S. Gov’t Validation Studies]. Analytical and Bioanalytical Chemistry, 394(8), 2119–2128. doi:10.1007/s00216-009-2912-8.

    Article  CAS  PubMed  Google Scholar 

  • Kieken, F., Pinel, G., Antignac, J., Garcia, P., Popot, M., Grall, M., et al. (2011). Development and application of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to reveal an illegal administration of recombinant equine growth hormone in horse from urinary and plasmatic biological signatures. Metabolomics, 7, 9.

    Article  Google Scholar 

  • Le Bizec, B., Pinel, G., & Antignac, J. P. (2009). Review: Options for veterinary drug analysis using mass spectrometry. Journal of Chromatography A, 1216, 8016–8034.

  • McGrath, T. F., van Meeuwen, J. A., Massart, A. C., de Pauw, E., Delahaut, P., Buijs, J., et al. (2013). Effect-based proteomic detection of growth promoter abuse. [Evaluation Studies Research Support, Non-U.S. Gov’t]. Analytical and Bioanalytical Chemistry, 405(4), 1171–1179. doi:10.1007/s00216-012-6534-1.

    Article  CAS  PubMed  Google Scholar 

  • Mooney, M. H., Bergwerff, A. A., van Meeuwen, J. A., Luppa, P. B., & Elliott, C. T. (2009). Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta, 637(1–2), 235–240. doi:10.1016/j.aca.2008.08.024.

    Article  CAS  PubMed  Google Scholar 

  • Nebbia, C., Urbani, A., Carletti, M., Gardini, G., Balbo, A., Bertarelli, D., et al. (2011). Novel strategies for tracing the exposure of meat cattle to illegal growth-promoters [Review]. Veterinary Journal, 189(1), 34–42. doi:10.1016/j.tvjl.2010.06.016.

    Article  CAS  Google Scholar 

  • Parker, C. E., & Borchers, C. H. (2014). Mass spectrometry based biomarker discovery, verification, and validation – Quality assurance and control of protein biomarker assays. Molecular Oncology,. doi:10.1016/j.molonc.2014.03.006.

    PubMed  Google Scholar 

  • Pinel, G., Weigel, S., Antignac, J. P., Mooney, M. H., Elliott, C., Nielen, M. W. F., et al. (2010). Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle. TrAC, Trends in Analytical Chemistry, 29(11), 1269–1280. doi:10.1016/j.trac.2010.06.010.

    Article  CAS  Google Scholar 

  • Pinel, G., Weigel, S., Lommen, A., Chéreau, S., Rambaud, L., Essers, M., et al. (2011). Assessment of two complementary LC-HRMS metabolomics strategies for the screening of anabolic steroid treatment in calves. Analytica Chimica Acta, 700, 10.

    Google Scholar 

  • Regal, P., Anizan, S., Antignac, J. P., Le Bizec, B., Cepeda, A., & Fente, C. (2011). Metabolomic approach based on liquid chromatography coupled to high resolution mass spectrometry to screen for the illegal use of estradiol and progesterone in cattle. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta, 700(1–2), 16–25. doi:10.1016/j.aca.2011.01.005.

    Article  CAS  PubMed  Google Scholar 

  • Riedmaier, I., & Pfaffl, M. W. (2013). Transcriptional biomarkers—high throughput screening, quantitative verification, and bioinformatical validation methods. Methods, 59(1), 3–9. doi:10.1016/j.ymeth.2012.08.012.

    Article  CAS  PubMed  Google Scholar 

  • Riedmaier, I., Becker, C., Pfaffl, M. W., & Meyer, H. H. (2009). The use of omic technologies for biomarker development to trace functions of anabolic agents. [Review]. Journal of Chromatography A, 1216(46), 8192–8199. doi:10.1016/j.chroma.2009.01.094.

    Article  CAS  PubMed  Google Scholar 

  • Rijk, J., Lommen, A., Essers, M., Groot, M. J., Van Hende, J., Doeswijk, T., et al. (2009). Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones. Analytical Chemistry, 81, 11.

    Article  Google Scholar 

Download references

Acknowledgments

The authors are very grateful to Régions “Pays de la Loire” and “Bretagne”, France, for their financial supports.

Author information

Authors and Affiliations

  1. Oniris, Laboratoire d’Étude des Résidus et Contaminants dans les Aliments (LABERCA), LUNAM Université, 44307, Nantes, France

    Gaud Dervilly-Pinel, Sylvain Chereau, Fabrice Monteau & Bruno Le Bizec

  2. Oniris, Unité Biologie, Epidémiologie et Analyse de Risque en Santé Animale (BIOEPAR), LUNAM Université, 44307, Nantes, France

    Nora Cesbron

Authors
  1. Gaud Dervilly-Pinel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvain Chereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nora Cesbron
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fabrice Monteau
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bruno Le Bizec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaud Dervilly-Pinel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dervilly-Pinel, G., Chereau, S., Cesbron, N. et al. LC-HRMS based metabolomics screening model to detect various β-agonists treatments in bovines. Metabolomics 11, 403–411 (2015). https://doi.org/10.1007/s11306-014-0705-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11306-014-0705-3

Keywords

Search

Navigation